cms glp-1 unveils $50 prescriptions for Medicare patients CMS just announced the Medicare

Microdosing GLP-1 strategies for stopping semaglutide and tirzepatide treatment and maintaining weight loss

Postprandial reduction in hunger was greater after RYGB than OAGB from baseline to 12 months

Find out when your semaglutide or tirzepatide actually expires and how to maximize effectiveness

Sugar-free berberine gummies with Ceylon cinnamon, milk thistle & ACV

Learn which body contouring procedures best support patients after semaglutide or GLP-1 treatment and how to address common post-weight loss concerns.

Backed by strong clinical evidence, GLP-1s are winning over doctors and patients alike and are reshaping treatment paradigms across comorbid conditions